Piper Sandler Just Hiked Humana Target to $254
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesPiper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
A surprising analyst upgrade helped StubHub Holdings stock crush expectations this week. This article breaks down the...
The travel sector is retooling pricing and perks as costs rise and consumers push for clarity. Southwest ditched free...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
Micron Technology faces its Q3 print after a sharp 13% drop on Tuesday, as investors weigh memory demand against AI i...
The first half of 2026 delivered a sharp downturn for Salesforce as AI-driven disruption and market rotation shook th...
As AI workloads surge, power reliability becomes a strategic bottleneck for data centers. This utility stock could of...
Investors preparing for the Q4 2025 call on tarsus (tars) 2025 earnings will want a clear, actionable plan. This guid...
Debt service now approaches $1 trillion annually as the interest on the $38.8 trillion national debt climbs, squeezin...
Coeur stock dropped again as inflation signals and gold prices shifted. This article breaks down what happened, what ...
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Argus boosts Exxon Mobil's target to $169, signaling confidence in higher 2026 output from Permian and Guyana and a r...